GH Research PLC Ordinary Shares (GHRS) is a publicly traded Healthcare sector company. As of November 13, 2026, GHRS trades at $19.22 with a market cap of $1.32B and a P/E ratio of 0.00. GHRS moved +0.00% today. Year to date, GHRS is +19.60%; over the trailing twelve months it is +23.27%. Its 52-week range spans $7.98 to $31.44. Analyst consensus is buy with an average price target of $54.50. Rallies surfaces GHRS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for GHRS, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $19.22 |
| Market Cap | $1.32B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $31.44 |
| 52-Week Low | $7.98 |
| Volume | 11.52K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
2 analysts cover GHRS: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $54.50.